Thursday, March 21, 2013

• Vaccinate Your Portfolio with These 3 Drugmakersat Motley Fool (Thu, Mar 21)

Friday, March 15, 2013

• Wall Street Transcript Interview with Steven Quay, CEO of Atossa Genetics, Inc. (ATOS)Wall Street Transcript (Fri, Mar 15)

Thursday, March 14, 2013

• What's Going On With Celldex?at Seeking Alpha (Thu, Mar 14)

Tuesday, March 12, 2013

• Encouraging Data Presented by GileadZacks (Tue, Mar 12)

Monday, March 11, 2013

• Pharmacyclics to Sell SharesZacks (Mon, Mar 11)
• Santarus Tops, Focus on ZegeridZacks (Mon, Mar 11)
• What Is Driving Celldex Therapeutics' Share Value?at Seeking Alpha (Mon, Mar 11)
• Outlook for Diagnostic Substances IndustryMarketwired (Mon, Mar 11)

Saturday, March 9, 2013

• New Star Analyst Rankings for Celldex Therapeutics, Inc.StarMine (Sat, Mar 9)
• 3 Humongous Health-Care Stocks This Weekat Motley Fool (Sat, Mar 9)

Friday, March 8, 2013

• Arena Cuts Loss, Misses EstimatesZacks (Fri, Mar 8)
• CELLDEX THERAPEUTICS, INC. Files SEC form 10-K, Annual ReportEDGAR Online (Fri, Mar 8)
• Analysts: Celldex Has New Revenue Sources and 4 New Opinions Investors Must Know Nowat Wall St. Cheat Sheet (Fri, Mar 8)
• Analysts: Honeywell Has Healthy Growth Plans and 4 More Research Notes to Read Nowat Wall St. Cheat Sheet (Fri, Mar 8)
• Analysts: BlackBerry is Managing Inventory Well and 4 New Opinions Investors Must Know Nowat Wall St. Cheat Sheet (Fri, Mar 8)
• Celldex price target raised to $16 from $13 at Cantorat theflyonthewall.com (Fri, Mar 8)
• Biotech Stock Mailbag: Celldex, TG Therapeutics, Sareptaat TheStreet (Fri, Mar 8)
• Seeking Opportunity: Creating A Plan Of Investment Actionat Seeking Alpha (Fri, Mar 8)

Thursday, March 7, 2013

• 4 Healthcare Stock Stories Not To Be Overlookedat Wall St. Cheat Sheet (Thu, Mar 7)
• Celldex Therapeutics' CEO Discusses Q4 2012 Results - Earnings Call Transcriptat Seeking Alpha (Thu, Mar 7)
• Celldex 4Q loss widens on higher R&D costsAP (Thu, Mar 7)
• Good News for Gilead's HIV PipelineZacks (Thu, Mar 7)
• Celldex shares defended at Leerinktheflyonthewall.com (Thu, Mar 7)
• Why Celldex Shares Droppedat Motley Fool (Thu, Mar 7)
• Celldex Therapeutics Earnings: Here’s Why Investors Don’t Like These Resultsat Wall St. Cheat Sheet (Thu, Mar 7)

Add CLDX News to My Yahoo!